Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders.

Kuvarzin, Savelii R; Sukhanov, Ilya; Onokhin, Kirill; Zakharov, Konstantin; Gainetdinov, Raul R

Kuvarzin, Savelii R; Sukhanov, Ilya; Onokhin, Kirill; Zakharov, Konstantin; Gainetdinov, Raul R.

Afiliación

Kuvarzin SR; Institute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Sukhanov I; Valdman Institute of Pharmacology, Pavlov Medical University, 197022 Saint Petersburg, Russia.
Onokhin K; Institute of Translational Biomedicine, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Zakharov K; Accellena Research and Development Inc., 199106 Saint Petersburg, Russia.
Gainetdinov RR; Accellena Research and Development Inc., 199106 Saint Petersburg, Russia.

Biomedicines ; 11(7)2023 Jul 13.

Article en En | MEDLINE | ID: mdl-37509616

Palabras clave

SEP-363856; TAAR; antipsychotic agents; dopamine; neuropsychiatric disorders; schizophrenia; trace amine-associated receptor 1; ulotaront

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google